Searchable abstracts of presentations at key conferences in endocrinology

ea0011p165 | Clinical case reports | ECE2006

Metformin-associated lactic acidosis in a caucasian woman precipitated by acute renal failure treated with bicarbonate haemodialysis

González Losada T , Del Olmo García L , Martinez de Icaya P , Alcázar Lázaro V , López del Val T , Pérez Pelayo M , Herranz Antolín S

Clinical case: A 51 year-old caucasian woman was admitted in the emergency room of our hospital with psicomotor agitation and confusion after four days of a profuse watery diarrhea, with 5 stools per day, abdominal cramps and vomiting. She started 500 mg of aspirin on her own initiative. Her medical profile included a type 2 diabetes treated with metformin 850 mg/12 hours and glyburide 7.5 mg/day, and hypertension treated with enalapril 20 mg/day. No renal imparement was docum...

ea0049ep99 | Adrenal medulla | ECE2017

Role of urinary fractionated metanephrines and catecholaminas in the diagnosis of pheochromocytoma/paraganglioma

Martinez-Triguero Ma Luisa , del Olmo Ma Isabel , del Olmo Rosa Camara , Alba Amparo , Fernandez Francis , Merino Juan Francisco , Laiz Begona

Introduction: Paragangliomas/pheochromocytomas present frequently with vague symptomatology which makes its diagnosis difficult and challenging. Cuantification of fractionated metanephrines and fractionated catecholamines in 24 h urine sample are used for diagnosis. There are situationes that can produce false positive results such as stress, drugs or smoking that must be taken into account.Patients and methods: Retrospective study on the requests made f...

ea0067o20 | Oral Presentations | EYES2019

Phenotype of patients carrying the c.709(-7-2)del PRKAR1A mutation in a large cohort of 40 patients

Abderrahmane Fatimetou , Raverot Gerald , Lefebvre Herve , Cardot-Bauters Catherine , Vantyghem Marie-Christine , Bertherat Jerome , Espiard Stephanie

Objective: To describe the Carney Complex (CNC) manifestations presented by patients harboring the PRKAR1A mutation c.709(-7-2)del (one of the three hotspots) in a large cohort of patients.Methods: Multicenter retrospective study. Age at the diagnosis or at the screening of the different CNC manifestations is described by mean ± standard deviation.Results: Forty patients [12 index cases, 27 females, 46±15 years o...

ea0070ep378 | Reproductive and Developmental Endocrinology | ECE2020

Clinical experience in puerta del mar university hospital anttending transsexual people (2015-2019)

Lara-Barea Almudena , Mateo Gavira Isabel , Larrán Escandón Laura , López Tinoco Cristina , Aguilar Diosdado Manuel

Introduction: Transsexuality is defined as discordance between one’s assigned sex at birth and that individual’s gender identity. Hormonal, anatomical, legal and psychosocial adaptations are present in most cases. Following recent changes to the Spanish legal framework, modifications have instaured to the model of attention for transsexual people in Andalusia. The aim of this study was to evaluate healthcare demand evolution in Trans People Attention Unit of Puerta...

ea0016p551 | Obesity | ECE2008

Prevalence of non alcoholic steatohepatitis in diabetic patients with morbid obesity

Segovia Raquel , Camara Rosa , Del Olmo Maribel , Ponce Jose , Navas Soledad , Argente Maria , Pinon Francisco

Non alcoholic steatohepatitis (EHNA) is diagnosed by hepatic biopsy. Its etiology is uncertain but obesity is present in 69–100% of all cases and type 2 diabetes mellitus (DM) in about 34–75%.Objectives: To study the prevalence of EHNA in morbidly obese patients and determine if there is a difference between the prevalence in patients with and without carbohydrate metabolism disorders.Patients and methods: Prospective stu...

ea0029p357 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Germ cell tumor of the pituitary–hypothalamic region: case series and clinical experience in the Hospital Universitario Virgen del Rocío

Tous Romero M. , Venegas E. , Soto Moreno A. , Dios Fuentes E. , Garcia Garcia E. , Oliva Rodriguez R. , Garcia Hernandez N. , Leal Cerro A.

Background: Germ cell tumors (germinoma, teratoma, embryonal carcinoma, yolk sac tumor and choriocarcinoma) constitute 0.3–3.4% of all primary intracraneal tumors. Germinoma is the most common and of better prognosis.Aim: Describing the behaviour of germ cell tumors of the pituitary–hypothalamic region: location, clinical characteristics, diagnosis and follow-up.Material and methods: Review of medical records of patients ...

ea0012oc13 | Placenta, bone and genetics | SFE2006

A kindred with Carney Complex due to a novel PRKAR1A gene mutation (c1067_1070 del AACG ins GCCCA)

Strey C , Randall J , Conroy S , Horvath A , Weissberg P , Berman L , Dixon A , Hoffman G , Cooper J , Firth H , Wood D , Simpson H , Chatterjee K , Stratakis C , Melvin A , Gurnell M

RP (a 60 yr-old male) was found to have multiple atrial myxomata, whilst being investigated for recurrent attacks of amaurosis fugax affecting his left eye. During the preceding twenty years he had undergone repeated resections of cutaneous tumours, which were reported as neurofibromata. A clinical diagnosis of Carney Complex (CNC) was made based on the presence of multiple cutaneous nodules and atrial myxomata. RP displayed mild acromegalic features, but no pigmentation abnor...

ea0099ep282 | Adrenal and Cardiovascular Endocrinology | ECE2024

Description of the x-linked adrenoleukodystrophy cohort from the csur unit of adult metabolic disorders at virgen del rocio university hospital (seville)

Gonzalez Gracia Lucia , Dios Fuentes Elena , Benitez Avila Rosa , Oulad Ahmed Bothayna , Soto Moreno Alfonso , Venegas Moreno Eva

Introduction and Objective: X-linked adrenoleukodystrophy (X-ALD) is a rare disease caused by a mutation in the ABCD1 gene (Xq28). It is characterized by the absence of very long-chain fatty acids (VLCFAs) degradation, leading to their accumulation primarily in the central and peripheral nervous system, adrenal cortex, and gonads. It presents a variable clinical spectrum and prognosis. The aim of our study is to describe the characteristics of all X-ALD patients under follow-u...

ea0090ep599 | Endocrine-related Cancer | ECE2023

Treatment with 177Lu-dotatate in metastasic advanced neuroendocrine tumors with positive expression of somatostatin receptors, in a third level hospital in Spain from 2015–2022

Giron Giselle , Hernandez Lorena , ISABEL DEL OLMO GARCIA MARIA , Camara-Gomez Rosa , Bello Pilar , Prado Stephan , Segura Angel , Francisco Merino Torres Juan

Introduction: 177Lu-Oxodotreotide(PRRT-Lu) has the approval by EMA and FDA since 2017 for the treatment of patients with gastro-entero-pancreatic neuroendocrine tumors(GEP-NET). However, in daily clinical practice it has also been used in other NET tumors such as paragangliomas, lung NET, medullary thyroid cancer, and others. The aim of this study is to describe the characteristics and follow-up of patients treated with PRRT-Lu in a third level hospital in Spain fro...

ea0049ep183 | Endocrine tumours and neoplasia | ECE2017

Treatment with (177Lu)-DOTATATE in patients with advanced metastatic somatostatin receptor-positive tumors

Martin-Portugues Antonio Ballesteros , Garcia Maria Isabel Del Olmo , Arques Pilar Bello , Huerta Angel Segura , Gomez Rosa Camara , Torres Juan Francisco Merino

Introduction: The NETTER 1 trial resulted in markedly longer progression-free survival (PFS), with preliminary evidence of an overall survival benefit. We report the results of PFS and safety of (177Lu)-DOTATATE in patients treated in our hospital between 2014 and 2016.Methods: Transversal and descriptive study of seven patients with advanced, progressive, somatostatin receptor-positive tumors who had received previous treatments. All of them were treate...